Highbridge Capital Management’s Elevance Health ELV Stock Holding History

Highbridge Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,656	Closed	-$3.3M	–	1319
2017 Q4	$3.3M	Buy	14,656 +5,575	+61%	+$1.19M	0.06%	316
2017 Q3	$1.72M	Buy	9,081 +7,981	+726%	+$1.52M	0.03%	462
2017 Q2	$207K	Sell	1,100 -23,900	-96%	-$4.29M	﹤0.01%	1100
2017 Q1	$4.13M	Buy	25,000 +11,000	+79%	+$1.75M	0.06%	328
2016 Q4	$2.01M	Buy	+14,000	New	+$1.87M	0.04%	378
2016 Q3	–	Sell	-229,515	Closed	-$29.6M	–	1399
2016 Q2	$30.1M	Buy	229,515 +164,455	+253%	+$22.5M	0.49%	46
2016 Q1	$9.04M	Buy	+65,060	New	+$8.69M	0.15%	177
2015 Q3	–	Sell	-1,436	Closed	-$236K	–	1598
2015 Q2	$236K	Buy	+1,436	New	+$229K	﹤0.01%	1227
2015 Q1	–	Sell	-45,084	Closed	-$5.67M	–	1438
2014 Q4	$5.67M	Buy	45,084 +28,458	+171%	+$3.52M	0.07%	286
2014 Q3	$1.99M	Sell	16,626 -90,943	-85%	-$10.4M	0.03%	486
2014 Q2	$11.6M	Buy	+107,569	New	+$11.1M	0.14%	170
2013 Q4	–	Sell	-21,515	Closed	-$1.8M	–	1124
2013 Q3	$1.8M	Buy	+21,515	New	+$1.84M	0.02%	535

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Highbridge Capital Management's ELV Position: Q1 2018 in Review

Highbridge Capital Management sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 14,656 shares — an estimated $3.3M sold.

Highbridge Capital Management first reported a position in ELV in Q3 2013 and held it in 12 quarters. The position peaked at $30.1M in Q2 2016. 924 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

Highbridge Capital Management reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
Highbridge Capital Management sold 14,656 Elevance Health shares in Q1 2018, an estimated $3.3M.
Highbridge Capital Management first reported a position in Elevance Health in Q3 2013 and held it in 12 quarters.
Highbridge Capital Management's Elevance Health position peaked at $30.1M in Q2 2016.
924 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.